ADVERTISEMENT
Margin Pressure Won't Ease For Makers Of Two Key Drugs
Drugmakers were optimistic that a fall in raw material costs will help. But that's unlikely to help. for now.
07 Sep 2022, 08:27 AM IST
Raw material prices are unlikely to ease anytime soon for makers of antibiotics and paracetamol analgesic because of high dependence on China for inputs."Elevated raw material import prices, U.S. pricing pressures owing to buyer consolidation, and revival in travel and marketing costs post-Covid will continue to negatively impact margins of drugmakers in FY23 by 200-250 basis points," Aniket Dani, director at Crisil Research told BQ ...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Free
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT